Clincosm LogoSign in Get a demo

dyslipidemia

Showing 1 - 25 of 348
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Dyslipidemia Trial in Seoul (Rosuvastatin Immediate-Release Tablet (IRT) 10mg, Rosuvastatin orally disintegrating tablet

Recruiting
  • Dyslipidemia
  • Rosuvastatin Immediate-Release Tablet (IRT) 10mg
  • Rosuvastatin orally disintegrating tablet (SUVARO®ODT) 10mg
  • Seoul, Korea, Republic of
    Division of Cardiology, Department of Internal Medicine, Yonsei
Nov 22, 2023

Epicardial Fat Thickness in Children With Familial Dyslipidemia

Not yet recruiting
  • Dyslipidemia
  • echoCARDIOGRAPHY
  • (no location specified)
Oct 22, 2023

Dyslipidemia Trial in Brooklyn (AZD0780, Rosuvastatin)

Recruiting
  • Dyslipidemia
  • Brooklyn, Maryland
    Research Site
Mar 27, 2023

Sickle Cell Disease, Dyslipidemia, Complication Trial in Pointe-à-Pitre, Le Lamentin (HDL2)

Recruiting
  • Sickle Cell Disease
  • +2 more
  • HDL2
  • Pointe-à-Pitre, Guadeloupe, France
  • +1 more
Mar 21, 2023

Blood Cholesterol With Mevalotin® Tablet Administration in

Recruiting
  • Dyslipidemia
  • Bucheon-si, Korea, Republic of
  • +58 more
Jan 30, 2023

Lipoprotein Metabolism in Normal Volunteers and High Levels of

Completed
  • Hypolipoproteinemia
  • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 20, 2023

    Type2 Diabetes, Dyslipidemia Trial in Worldwide (K-877, Placebo)

    Terminated
    • Type2 Diabetes
    • Dyslipidemia
    • Birmingham, Alabama
    • +887 more
    Dec 20, 2022

    Dyslipidemia Trial in Glendale, Brooklyn (AZD0780, Placebo)

    Recruiting
    • Dyslipidemia
    • Glendale, California
    • +2 more
    Nov 9, 2022

    Dyslipidemia, Atherosclerosis, Acute Coronary Syndrome Trial in Dallas (RVX000222, Placebo)

    Completed
    • Dyslipidemia
    • +3 more
    • Dallas, Texas
      Covance Clinical Research Unit, Inc.
    Nov 1, 2022

    Dyslipidemia Trial in Japan (Part A:Placebo, Part A:AZD8233, Part B:Placebo)

    Completed
    • Dyslipidemia
    • Part A:Placebo
    • +5 more
    • Chiyoda-ku, Japan
    • +6 more
    Oct 3, 2022

    Dyslipidemia, Atherosclerosis, Diabetes, Type 2 Trial (Choline fenofibrate, Policosanol)

    Recruiting
    • Dyslipidemia
    • +2 more
    • Seongnam, Gyeonggi, Korea, Republic of
      SNUBH
    Oct 1, 2022

    Diabetes, Myocardial Infarction, Stroke Trial in United States (Lifestyle Intervention, Diabetes Support and Education)

    Completed
    • Diabetes
    • +5 more
    • Lifestyle Intervention
    • Diabetes Support and Education
    • Birmingham, Alabama
    • +17 more
    Sep 27, 2022

    Treatment of Newvast® Tab(Atorvastatin) in Korean Dyslipidemia

    Completed
    • Dyslipidemia
    • single arm, single group(No interventional)
    • Seoul, Korea, Republic of
      Hanmi Pharmaceutical Company Limited
    Sep 22, 2022

    Dyslipidemia and Diabetic Retinopathy

    Recruiting
    • Diabetic Retinopathy
    • Dyslipidemia
    • 15 subjects with Non Proliferative Diabetic Retinopathy(mild, moderate and severe). 15 subjects with Proliferative Diabetic Retinopathy
    • Healthy Controls 15 age matched control subjects
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Aug 11, 2022

    Dyslipidemia, Hypercholesterolemia, High Cholesterol Trial in Japan (Obicetrapib)

    Recruiting
    • Dyslipidemia
    • +2 more
    • Fukuyama, Japan
    • +9 more
    Aug 10, 2022

    Type 2 Diabetes, Dyslipidemia Trial (BERLIM 25/10 association, EMPAGLIFLOZIN, ROSUVASTATIN CALCIUM)

    Not yet recruiting
    • Type 2 Diabetes Mellitus
    • Dyslipidemia
    • BERLIM 25/10 association
    • +5 more
    • (no location specified)
    Aug 3, 2022

    Hypertriglyceridemia, Dyslipidemia Trial in Campinas (Cipros 10 association, Crestor 10 mg)

    Recruiting
    • Hypertriglyceridemia
    • Dyslipidemia
    • Cipros 10 association
    • Crestor 10 mg
    • Campinas, São Paulo, Brazil
      Allergisa
    Aug 3, 2022

    Dyslipidemia Trial in Worldwide (Evolocumab, Placebo)

    Completed
    Has Results
    • Dyslipidemia
    • Evolocumab
    • Placebo
    • Birmingham, Alabama
    • +1286 more
    Jul 15, 2022

    Effectiveness and Safety of Amosartan Q Tablet

    Completed
    • Hypertension
    • Dyslipidemia
    • Amosartan Q tablet
    • Seoul, Korea, Republic of
      Hanmi Pharmaceutical Company Limited
    Jul 5, 2022

    "My A:Care" and "Smart Coach" on Lipid-lowering Treatment

    Recruiting
    • Dyslipidemia
    • My A:care
    • Smart Coach
    • Khon Kaen, Thailand
      Chatlert Mueang Pongchaiyakul
    May 9, 2022

    Dyslipidemia, Hypertension Trial in Seoul (LivaloVA, LivaloV, VA)

    Recruiting
    • Dyslipidemia
    • Hypertension
    • Seoul, Korea, Korea, Republic of
      Gangdong Sacred Heart Hospital
    Apr 10, 2022

    Dyslipidemia Trial in Worldwide (Evolocumab)

    Completed
    • Dyslipidemia
    • Evolocumab
    • Birmingham, Alabama
    • +197 more
    Apr 4, 2022

    Dyslipidemia Trial in Worldwide (Evolocumab)

    Completed
    • Dyslipidemia
    • Aalst, Belgium
    • +84 more
    Mar 8, 2022

    Dyslipidemia Trial in Worldwide (survey)

    Active, not recruiting
    • Dyslipidemia
    • survey
    • Kuwait, Kuwait
    • +3 more
    Mar 7, 2022

    Dyslipidemia Trial (Ezetimibe/simvastatin, Other Statin)

    Withdrawn
    • Dyslipidemia
    • (no location specified)
    Feb 7, 2022